Open Access Open Access  Restricted Access Subscription or Fee Access

Brief Review on Active Immunization

Subha Parameshwaran

Abstract


Vaccination is a term used for the prevention of diseases through the administration of live or killed antigens. A vaccine is modified organism or product. The vaccine gives adequate and long-lasting immunity against the disease. It should be safe, effective and should generate memory. The proposed vaccine may be available as monovalent/combination, single dose/multi-dose, and liquid/lyophilized. A number of issues need to be considered while choosing the presentation/formulation. These include current and proposed immunization schedule, number of injections per visit, cold storage space, vaccine wastage, injection safety equipment, staff training and supervision, recording and reporting mechanisms, and program costs. Live vaccines stimulate the B cells into producing antibodies. There are various types of vaccine live, killed, polysaccharide, synthetic, and recombinant vaccines. This is important for developing countries, where cost needs to be considered. Newer vaccines are available, for which the feasibility and the efficacy needs to be evaluated. These can be incorporated only after evaluations.

Keywords


active immunization, passive immunization, vaccine

Full Text:

PDF

References


Park K. Park's Textbook of Preventive and Social Medicine. 21st ed. Jabalpur: Banarsidas Bhanot Publishers; 2011.

Choudhury P. Scheduling of Vaccine. In: IAP Text Book of Vaccines. Vashishtha V.M., Agarwal R., Sukumaran T., Eds. New Delhi: Indian Academy of Pediatrics, Jaypee Brothers; 2013.

WHO vaccine-preventable diseases: Monitoring system. 2013 global Summary. Available from http://apps.who.int/immunization_monitoring/ global summary/schedules. [Accessed Nov 26, 2013].

Siegrist C.A. Vaccine Immunology. In: Vaccines. 5th Edn., Plotkin S.A., Orenstein W., Offit P., Eds. Saunders Elsevier; 2008.

Lee C.J., Lee L.H., Lu C.s., et al. Bacterial polysaccharides as vaccine-immunity and chemical characterization. Adv Exp Med Biol. 2001; 491: 453–71p.

Kobrynski L.J., Sousa A.O., Nahmias A.J., et al. Cutting edge: antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8+ T cells. J Immunol. 2005; 174: 1787–90p.

Kamat D., Madhur A. Vaccine Immunology. In: IAP Textbook of Vaccines. Vashishtha V.M., Ed. New Delhi: Jaypee Bros; 2013.

BCG Vaccine, WHO position paper, Weekly epidemiological record 2004; 79: 25–40. Available from: http://www.who.int /wer/2004 /en/wer7904.pdf.

John T.J., Vashishtha V.M. Eradicating poliomyelitis: India's journey from hyper endemic to polio-free status. Indian J Med Res. 2013; 137: 881–89p.

Sutter R.W., Kew O.M., Cochi S.L. Poliovirus vaccine live. In: Vaccines. Ch 26.

John T.J., Choudhury P. Accelerating measles control in India: opportunity and obligation to act now. Indian Pediatr. 2009; 46: 939–43p.

Tiwari S., Singh R.K., Tiwari R., Dhole T.N. Japanese encephalitis: a review of the Indian perspective. Braz J Infect Dis. 2012; 16: 564–73p.

Kay A., Chen L.H., Sisti M., et al. Yellow fever vaccine seroconversion in travelers. Am J Trop Med Hyg. 2011; 85: 748–9p.

Kothari A., Pruthi A., Chugh T.D. The burden of enteric fever. J Infect Dev Ctries 2008; 2: 253–9p.

Khan N., Shastri J., Aigal U., et al. Resurgence of diphtheria in the vaccination era. Indian J Med Microbiol. 2007; 25: 434–7p.

Liko J, et al. Priming with whole-cell versus a cellular pertussis vaccine. N. Engl J Med. 2013; 368: 581–2p.

Gupta A. India's Universal immunization program me. GAVI Alliance Board Meeting; 2012. Available from www.gavialliance.org /about/.../12.../16---country- presentation – India.

Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec. 2011; 86: 521–39p.

Macneil J.R. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine. Pediatr Infect Dis J. 2011; 30: 451–5p.

Hepatitis B vaccines: WHO Position Paper. Wkly Epidemiol Rec. 2009; 84: 405–20p.

Jack A.D., et al. What level of hepatitis B antibody is protective? J Infect Dis. 1999; 179: 489–92p.

Human Papilloma Virus; Vaccines. WHO Position Paper. Wkly Epidemiol Rec 2009; 84: 117–32p.

Bhatla N., Lal N., Bao Y.P., et al. A meta-analysis of human Papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine. 2008; 26: 2811–7p.

Decker M.D., Edwards K.M., Bogaerts H.H. Combination vaccines. In: Vaccine. Plotkin S., Orenstein W., Offit P., Eds., 5th Edn., Philadelphia: Saunders, Elsevier; 2008. 1069p.

Daniel H., Streatfield J. Medical molecular farming production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 2001; 6: 219–26p.




DOI: https://doi.org/10.37628/ijcbcp.v1i2.43

Refbacks

  • There are currently no refbacks.